FIELD: medicine; oncology.
SUBSTANCE: differential pathologic diagnostics of adenocarcinoma liver metastases is performed by comparison of analysis results of trepan biopsy materials prepared by standard techniques and tested according to histologic and cytologic methods. Metastasis parenchyma structure detected by histologic analysis is compared to cell complex type prevailing in quantitative respect in cytologic preparation. In case liver secondary tumour parenchyma of tubular structure is detected while rosette-like cell complex prevails, moderately differentiated stomach cancer metastasis is diagnosed. In case liver secondary tumour parenchyma of tubular structure is detected while catenate cell complex prevails, low-differentiated stomach cancer metastasis is diagnosed. In case liver secondary tumour parenchyma of tubular structure is detected while papillary cell complex prevails, colorectal cancer metastasis is differentiated. In case liver secondary tumour parenchyma of tubular structure is detected while solid cell complex prevails, high-differentiated and moderately differentiated pancreas cancer metastasis or uterus cancer metastasis is diagnosed. In case liver secondary tumour parenchyma of tubular structure is detected while papillary and rosette-like cell complexes prevail, breast cancer metastasis is diagnosed. In case liver secondary tumour parenchyma of solid structure is detected while rosette-like cell complex prevails, prostate cancer metastasis is diagnosed. In case liver secondary tumour parenchyma of solid structure is detected while catenate cell complex prevails, pulmonary adenocarcinoma metastasis is diagnosed. In case liver secondary tumour parenchyma of solid structure is detected while papillary cell complex prevails, ovarian carcinoma metastasis is diagnosed. In case liver secondary tumour parenchyma of glandular structure is detected while rosette-like cell complex prevails, gallbladder carcinoma metastasis is diagnosed. In case liver secondary tumour parenchyma of glandular structure is detected while papillary cell complex prevails, low-differentiated pancreas cancer metastasis is diagnosed.
EFFECT: method provides improved accuracy of differential diagnostics and cost reduction of pathologic analysis.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIFFERENTIAL DIAGNOSTIC OF PRIMARY AND SECONDARY LIVER CANCER | 2007 |
|
RU2327422C1 |
METHOD FOR DIAGNOSTIC OF POORLY DIFFERENTIATED NEUROENDOCRINE GASTRIC CANCER | 2015 |
|
RU2613300C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF THYROID NEOPLASMS | 2019 |
|
RU2705110C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF ASCITIC-INFILTRATIVE OVARIAN CANCER AND ABDOMINAL TUBERCULOSIS | 2015 |
|
RU2585959C1 |
METHOD OF PREDICTING EFFICIENCY OF ANTITUMOUR TREATMENT | 2009 |
|
RU2411913C1 |
METHOD FOR DIAGNOSTICS OF ENDOMETRIUM PATHOLOGY IN PATIENTS WITH HYSTEROMYOMA | 2007 |
|
RU2334987C1 |
DIFFERENTIAL METHOD FOR DIAGNOSING HYPERPLASIA, DYSPLASIA AND CARCINOMA OF THE PROSTATE | 1999 |
|
RU2156977C1 |
METHOD FOR CARRYING OUT ULTRASONIC DIAGNOSTIC EXAMINATION FOR DETERMINING INDIVIDUAL RESIDUAL OVARIAN TUMOR SENSITIVITY TO CHEMOTHERAPY | 2002 |
|
RU2239362C2 |
METHOD FOR DIAGNOSIS OF MALIGNANT PROGRESSION OF LARGE INTESTINE TUMORS | 2002 |
|
RU2213781C1 |
METHOD FOR EARLY DIAGNOSIS OF NEOPLASTIC TRANSFORMATION OF ENDOMETRIOID OVARIAN CYSTS | 2020 |
|
RU2730952C1 |
Authors
Dates
2008-08-10—Published
2007-01-09—Filed